134 related articles for article (PubMed ID: 9615198)
1. Molecular cytogenetics of bladder cancer progression.
Sauter G; Moch H; Mihatsch MJ; Gasser TC
Eur Urol; 1998; 33 Suppl 4():9-10. PubMed ID: 9615198
[No Abstract] [Full Text] [Related]
2. Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro.
Ratliff TL
J Urol; 2005 Nov; 174(5):2065. PubMed ID: 16217396
[No Abstract] [Full Text] [Related]
3. DNA methylation in bladder cancer.
Jones PA; Gonzalgo ML; Tsutsumi M; Bender CM
Eur Urol; 1998; 33 Suppl 4():7-8. PubMed ID: 9615197
[No Abstract] [Full Text] [Related]
4. Molecular cytogenetic alterations associated with rapid tumor cell proliferation in advanced urinary bladder cancer.
Tomovska S; Richter J; Süess K; Wagner U; Rozenblum E; Gasser TC; Moch H; Mihatsch MJ; Sauter G; Schraml P
Int J Oncol; 2001 Jun; 18(6):1239-44. PubMed ID: 11351257
[TBL] [Abstract][Full Text] [Related]
5. Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder.
Gronau S; Menz CK; Melzner I; Hautmann R; Möller P; Barth TF
Virchows Arch; 2002 Apr; 440(4):436-40. PubMed ID: 11956826
[TBL] [Abstract][Full Text] [Related]
6. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.
Hopman AH; van Hooren E; van de Kaa CA; Vooijs PG; Ramaekers FC
Mod Pathol; 1991 Jul; 4(4):503-13. PubMed ID: 1924281
[TBL] [Abstract][Full Text] [Related]
7. Numerical aberrations of chromosome 8 and allelic loss at 8p in non-muscle-invasive urothelial carcinomas of the urinary bladder.
Erbersdobler A; Kaiser H; Friedrich MG; Henke RP
Eur Urol; 2000 Nov; 38(5):590-6. PubMed ID: 11096241
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma.
Eleuteri P; Grollino MG; Pomponi D; De Vita R
Eur J Cancer; 2001 Aug; 37(12):1496-503. PubMed ID: 11506956
[TBL] [Abstract][Full Text] [Related]
9. Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer.
Neuhaus M; Wagner U; Schmid U; Ackermann D; Zellweger T; Maurer R; Alund G; Knönagel H; Rist M; Moch H; Mihatsch MJ; Gasser TC; Sauter G
Hum Pathol; 1999 Jan; 30(1):81-6. PubMed ID: 9923932
[TBL] [Abstract][Full Text] [Related]
10. Detection of genetic aberrations in bladder cancer using in situ hybridization.
Ramaekers FC; Hopman AH
Ann N Y Acad Sci; 1993 Mar; 677():199-213. PubMed ID: 8098592
[No Abstract] [Full Text] [Related]
11. Detection of chromosomal imbalances in papillary bladder tumors by comparative genomic hybridization.
Prat E; Bernués M; Caballín MR; Egozcue J; Gelabert A; Miró R
Urology; 2001 May; 57(5):986-92. PubMed ID: 11337313
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of outcome in bladder cancer.
Cote RJ; Chatterjee SJ
Cancer J Sci Am; 1999; 5(1):2-15. PubMed ID: 10188054
[No Abstract] [Full Text] [Related]
13. Studies on growth of human bladder tumors. The relationship between the proliferative cell population, the chromosome pattern and histology.
Neagu V; Lazar C; Mares V; Pop T; Ioanid PC
Neoplasma; 1979; 26(2):195-200. PubMed ID: 471126
[No Abstract] [Full Text] [Related]
14. Sex chromosome abnormalities in bladder cancer: Y polysomies are linked to PT1-grade III transitional cell carcinoma.
Panani AD; Roussos C
Anticancer Res; 2006; 26(1A):319-23. PubMed ID: 16475713
[TBL] [Abstract][Full Text] [Related]
15. A case of transitional cell carcinoma of the bladder with a del(9)(q11q21.2).
Bernués M; Casadevall C; Miró R; Caballín MR; Gelabert A; Egozcue J
Cancer Genet Cytogenet; 1993 Aug; 69(1):76-7. PubMed ID: 8374907
[TBL] [Abstract][Full Text] [Related]
16. Genetic aberrations of NAT2 and chromosome 8: their association with progression in transitional cell carcinoma of the urinary bladder.
Watters AD; Stacey MW; Going JJ; Grigor KM; Cooke TG; Sim E; Bartlett JM
Urol Int; 2001; 67(3):235-9. PubMed ID: 11598453
[TBL] [Abstract][Full Text] [Related]
17. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
Vanni R; Scarpa RM
Cancer Res; 1986 Sep; 46(9):4873. PubMed ID: 3731134
[No Abstract] [Full Text] [Related]
18. In vivo assessment of urinary bladder malignancy.
Karr JP; Pontes JE; Murphy GP; Gibas Z; Sandberg AA
Prog Clin Biol Res; 1984; 162A():331-46. PubMed ID: 6592614
[No Abstract] [Full Text] [Related]
19. Interphase cytogenetic studies of bladder cancer.
Wang MR; Perissel B; Taillandier J; Malet P
Bull Cancer; 1994 Dec; 81(12):1060-6. PubMed ID: 7742594
[TBL] [Abstract][Full Text] [Related]
20. DNA flow cytometric analysis and numerical chromosome 9 aberrations detected by interphase cytogenetics in superficial bladder TCC.
Eleuteri P; Grollino MG; Pomponi D; Calugi G; Rocchi M; De Vita R
Eur J Histochem; 1997; 41 Suppl 2():161-2. PubMed ID: 9859830
[No Abstract] [Full Text] [Related]
[Next] [New Search]
